Phase 1 Small Cell Lung Cancer Extensive Stage Clinical Trials
6 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–6 of 6 trials
Recruiting
Phase 1Phase 2
A Clinical Study of Gocatamig (MK-6070) and Infinatamab Deruxtecan (MK-2400) in People With Small Cell Lung Cancer (MK-6070-003)
Small Cell Lung Cancer Extensive Stage
Merck Sharp & Dohme LLC170 enrolled15 locationsNCT07227597
Recruiting
Phase 1
Personalized Radiotherapy for Individualized Treatment Strategies and Monitoring (PRISM)
Solid Tumor, AdultBrain MetastasesSmall Cell Lung Cancer Extensive Stage
University of Texas Southwestern Medical Center45 enrolled1 locationNCT07139990
Recruiting
Phase 1Phase 2
Quaratusugene Ozeplasmid (Reqorsa) and Atezolizumab Maintenance Therapy in ES-SCLC Patients
Small Cell Lung Cancer Extensive Stage
Genprex, Inc.62 enrolled17 locationsNCT05703971
Recruiting
Phase 1
DLL3-Directed Chimeric Antigen Receptor T-cells in Subjects With Extensive Stage Small Cell Lung Cancer
Small Cell Lung Cancer Extensive StageLarge Cell Neuroendocrine Carcinoma of the Lung
Legend Biotech USA Inc41 enrolled4 locationsNCT05680922
Recruiting
Phase 1
Phase I Clinical Study of α-PD-L1/DLL3 CAR-T in Patients With R/R SCLC
Small Cell Lung Cancer Extensive Stage
Sichuan University28 enrolled1 locationNCT06348797
Recruiting
Phase 1Phase 2
IN10018 Combination Therapy in Treatment-naïve ES-SCLC
Small Cell Lung Cancer Extensive Stage
InxMed (Shanghai) Co., Ltd.120 enrolled3 locationsNCT06030258